SEPTInvestingStart Free

RNAC SCHEDULE 13G/A: SEC filing

A Schedule 13G/A amendment was

Filed with the SEC on · accession 0000312069-26-000266

RNAC filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 6, 2026. A Schedule 13G/A amendment was filed regarding beneficial ownership of Cartesian Therapeutics, Inc. (RNAC).

Summary of the filing

A Schedule 13G/A amendment was filed regarding beneficial ownership of Cartesian Therapeutics, Inc. (RNAC). The filing text provided is only an EDGAR directory listing and does not disclose the holder, ownership percentage, or any change in position.

For details, click here →

Key details

IssuerCartesian Therapeutics, Inc.

✦ Ask GOAX AI about this filing — what it means for RNAC, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for RNAC?

Click here

Frequently asked questions

What did RNAC file with the SEC on Nov 6, 2026?

RNAC filed a SCHEDULE 13G/A (SEC filing). A Schedule 13G/A amendment was filed regarding beneficial ownership of Cartesian Therapeutics, Inc. (RNAC). The filing text provided is only an EDGAR directory listing and does not disclose the holder, ownership percentage, or any change in position.

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

Other RNAC SEC filings

Get alerts when RNAC files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
RNAC overviewRNAC analysisRNAC newsLatest SEC filings